Skip to content

Head to head

GLOW blend against GHK-Cu

The blend against the ingredient that makes up most of it. In a typical GLOW vial GHK-Cu is 71.4 percent of the powder, which makes it closer to a copper peptide vial with two additives than to a three-way stack, and no study has tested the combination.

Column A

GLOW blend

GLOW (GHK-Cu + BPC-157 + TB-500)

A three-peptide vendor blend, typically 50 mg GHK-Cu with 10 mg each of BPC-157 and TB-500, marketed for skin and recovery. No study has tested the combination. GHK-Cu is 71.4% of the powder, so the vial carries roughly 7.9 mg of elemental copper and this is closer to a copper peptide vial with two additives than to an equal three-way stack.

Column B

GHK-Cu

Copper Tripeptide-1 (GHK-Cu)

A naturally occurring copper-binding tripeptide widely used in skincare and studied for wound healing and skin remodeling.

Side by side, on the facts we can check

AttributeGLOW blendGHK-Cu
CategoryCosmeticHealing & Recovery
FDA statusNot approved; the combination has never been evaluated. FDA staff evaluated BPC-157 and TB-500 separately for the July 2026 Pharmacy Compounding Advisory Committee and found no adequate human data for either.Not an approved drug; permitted as a cosmetic ingredient
Half-lifeNot defined for the blend. No pharmacokinetic study of the mixture exists.Short (topical use)
Molecular weightA mixture. GHK-Cu is about 403 Da as the copper complex, BPC-157 1,419.5 Da, and the Ac-LKKTETQ fragment sold as TB-500 about 889 Da.340.38 Da (free peptide); 402.92 Da (the copper complex, PubChem CID 71587328)
MechanismAssumed additive, on no evidence that it is. GHK-Cu delivers copper and drove collagen and glycosaminoglycan production in fibroblast culture and in rat wound chambers. BPC-157 and TB-500 act through the repair pathways set out on their own pages, with the standing caveat that TB-500 is a seven amino acid fragment rather than the thymosin beta 4 protein whose literature is usually quoted for it. No study describes the three together, their compatibility in one acidic copper-containing solution, or a combined dose.Delivers copper and modulates genes involved in tissue remodeling, stimulating collagen and glycosaminoglycan synthesis and supporting wound repair.
Human studies cited30
Legal status, USNot approved; sold 'for research use only'Permitted in cosmetics; not an approved drug
open the GLOW blend profileopen the GHK-Cu profile

Frequently asked questions

What is the difference between GLOW blend and GHK-Cu?

GLOW blend: A three-peptide vendor blend, typically 50 mg GHK-Cu with 10 mg each of BPC-157 and TB-500, marketed for skin and recovery. No study has tested the combination. GHK-Cu is 71.4% of the powder, so the vial carries roughly 7.9 mg of elemental copper and this is closer to a copper peptide vial with two additives than to an equal three-way stack. GHK-Cu: A naturally occurring copper-binding tripeptide widely used in skincare and studied for wound healing and skin remodeling.

Which has stronger research evidence, GLOW blend or GHK-Cu?

This database does not grade compounds. It counts what was run in people: 3 of the 10 studies cited on the GLOW blend profile were human work, against 0 of 3 for GHK-Cu. Those counts are of our own citation lists and understate any larger literature, and neither is a recommendation.

Are GLOW blend and GHK-Cu FDA-approved?

GLOW blend: Not approved; the combination has never been evaluated. FDA staff evaluated BPC-157 and TB-500 separately for the July 2026 Pharmacy Compounding Advisory Committee and found no adequate human data for either.. GHK-Cu: Not an approved drug; permitted as a cosmetic ingredient.

Related posts

Blog articles that cover GLOW blend or GHK-Cu, newest first.

Reviewed Sep 2026. This page sets two published records side by side. It is educational, it is not medical advice, and it contains no dosing protocols or recommendations for personal use.